Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Clinical trial NCT06858878 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06858878
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-17
- Primary completion
- 2027-01-21
- Enrollment
- 1105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.